Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy

Rebecca Rickaby, Louis Y El Khoury, Tom Samiric, Stuart M Raleigh

Research output: Contribution to journalArticle

2 Downloads (Pure)

Abstract

Patellar tendinopathy (PT) is a debilitating condition that often affects those who are physically active. Gene variation is known to contribute to human tendinopathy but the role of DNA methylation, as an epigenetic factor, has only recently been discovered. Using a case-control approach, we sought to determine whether differences existed between the methylation status of the MMP11 gene promoter in patellar tendinopathy compared to healthy tendon. We used PCR and pyrosequencing to interrogate the methylation profiles of 4 CpG sites (areas of the genome rich in C/G nucleotides) upstream of the MMP11 gene in DNA from males with PT (n = 10) and those with healthy tendon (n = 10). We also conducted a correlation analysis to establish whether age influenced methylation in the PT patients and controls. We found a significant (p = 0.045) difference in the methylation status of a single CpG site 65 base pairs (bp) upstream of the MMP11 promoter between the PT group and controls. There were no other differences in the extent of MMP11 promoter methylation between the two groups. Interestingly, we also found that in controls the degree of methylation at a second CpG site, 55 bp upstream of the first exon, tentatively correlated (r = 0.77, p = 0.009) with age. However, the correlation did not reach significance when a potential outlier was removed. This is the first study to show an epigenetic alteration to a member of the MMP gene family in human patellar tendinopathy. The data add to our understanding of how epigenetics should be considered when developing appropriate risk models.

Original languageEnglish
Pages (from-to)155-159
Number of pages5
JournalJournal of Sports Science and Medicine
Volume18
Issue number1
Publication statusPublished - 11 Feb 2019

Fingerprint

Tendinopathy
Epigenomics
Methylation
Genes
Base Pairing
Tendons
DNA Methylation
Matrix Metalloproteinases
Exons
Nucleotides
Genome
Polymerase Chain Reaction
Control Groups
DNA

Bibliographical note

This work is licensed under a Creative Commons License Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Keywords

  • Epigenetics
  • Genetics
  • Sports injury
  • Tendinopathy
  • Tendon

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy. / Rickaby, Rebecca; El Khoury, Louis Y; Samiric, Tom; Raleigh, Stuart M.

In: Journal of Sports Science and Medicine, Vol. 18, No. 1, 11.02.2019, p. 155-159.

Research output: Contribution to journalArticle

Rickaby, Rebecca ; El Khoury, Louis Y ; Samiric, Tom ; Raleigh, Stuart M. / Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy. In: Journal of Sports Science and Medicine. 2019 ; Vol. 18, No. 1. pp. 155-159.
@article{1e773ab1e56840e4b25479b9cbb8009b,
title = "Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy",
abstract = "Patellar tendinopathy (PT) is a debilitating condition that often affects those who are physically active. Gene variation is known to contribute to human tendinopathy but the role of DNA methylation, as an epigenetic factor, has only recently been discovered. Using a case-control approach, we sought to determine whether differences existed between the methylation status of the MMP11 gene promoter in patellar tendinopathy compared to healthy tendon. We used PCR and pyrosequencing to interrogate the methylation profiles of 4 CpG sites (areas of the genome rich in C/G nucleotides) upstream of the MMP11 gene in DNA from males with PT (n = 10) and those with healthy tendon (n = 10). We also conducted a correlation analysis to establish whether age influenced methylation in the PT patients and controls. We found a significant (p = 0.045) difference in the methylation status of a single CpG site 65 base pairs (bp) upstream of the MMP11 promoter between the PT group and controls. There were no other differences in the extent of MMP11 promoter methylation between the two groups. Interestingly, we also found that in controls the degree of methylation at a second CpG site, 55 bp upstream of the first exon, tentatively correlated (r = 0.77, p = 0.009) with age. However, the correlation did not reach significance when a potential outlier was removed. This is the first study to show an epigenetic alteration to a member of the MMP gene family in human patellar tendinopathy. The data add to our understanding of how epigenetics should be considered when developing appropriate risk models.",
keywords = "Epigenetics, Genetics, Sports injury, Tendinopathy, Tendon",
author = "Rebecca Rickaby and {El Khoury}, {Louis Y} and Tom Samiric and Raleigh, {Stuart M}",
note = "This work is licensed under a Creative Commons License Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.",
year = "2019",
month = "2",
day = "11",
language = "English",
volume = "18",
pages = "155--159",
journal = "Journal of Sports Science and Medicine",
issn = "1303-2968",
publisher = "Department of Sports Medicine, Medical Faculty of Uludag University",
number = "1",

}

TY - JOUR

T1 - Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy

AU - Rickaby, Rebecca

AU - El Khoury, Louis Y

AU - Samiric, Tom

AU - Raleigh, Stuart M

N1 - This work is licensed under a Creative Commons License Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

PY - 2019/2/11

Y1 - 2019/2/11

N2 - Patellar tendinopathy (PT) is a debilitating condition that often affects those who are physically active. Gene variation is known to contribute to human tendinopathy but the role of DNA methylation, as an epigenetic factor, has only recently been discovered. Using a case-control approach, we sought to determine whether differences existed between the methylation status of the MMP11 gene promoter in patellar tendinopathy compared to healthy tendon. We used PCR and pyrosequencing to interrogate the methylation profiles of 4 CpG sites (areas of the genome rich in C/G nucleotides) upstream of the MMP11 gene in DNA from males with PT (n = 10) and those with healthy tendon (n = 10). We also conducted a correlation analysis to establish whether age influenced methylation in the PT patients and controls. We found a significant (p = 0.045) difference in the methylation status of a single CpG site 65 base pairs (bp) upstream of the MMP11 promoter between the PT group and controls. There were no other differences in the extent of MMP11 promoter methylation between the two groups. Interestingly, we also found that in controls the degree of methylation at a second CpG site, 55 bp upstream of the first exon, tentatively correlated (r = 0.77, p = 0.009) with age. However, the correlation did not reach significance when a potential outlier was removed. This is the first study to show an epigenetic alteration to a member of the MMP gene family in human patellar tendinopathy. The data add to our understanding of how epigenetics should be considered when developing appropriate risk models.

AB - Patellar tendinopathy (PT) is a debilitating condition that often affects those who are physically active. Gene variation is known to contribute to human tendinopathy but the role of DNA methylation, as an epigenetic factor, has only recently been discovered. Using a case-control approach, we sought to determine whether differences existed between the methylation status of the MMP11 gene promoter in patellar tendinopathy compared to healthy tendon. We used PCR and pyrosequencing to interrogate the methylation profiles of 4 CpG sites (areas of the genome rich in C/G nucleotides) upstream of the MMP11 gene in DNA from males with PT (n = 10) and those with healthy tendon (n = 10). We also conducted a correlation analysis to establish whether age influenced methylation in the PT patients and controls. We found a significant (p = 0.045) difference in the methylation status of a single CpG site 65 base pairs (bp) upstream of the MMP11 promoter between the PT group and controls. There were no other differences in the extent of MMP11 promoter methylation between the two groups. Interestingly, we also found that in controls the degree of methylation at a second CpG site, 55 bp upstream of the first exon, tentatively correlated (r = 0.77, p = 0.009) with age. However, the correlation did not reach significance when a potential outlier was removed. This is the first study to show an epigenetic alteration to a member of the MMP gene family in human patellar tendinopathy. The data add to our understanding of how epigenetics should be considered when developing appropriate risk models.

KW - Epigenetics

KW - Genetics

KW - Sports injury

KW - Tendinopathy

KW - Tendon

UR - http://www.scopus.com/inward/record.url?scp=85061968819&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 155

EP - 159

JO - Journal of Sports Science and Medicine

JF - Journal of Sports Science and Medicine

SN - 1303-2968

IS - 1

ER -